Humana Inc. (NYSE:HUM) Receives Average Rating of “Hold” from Brokerages

Humana Inc. (NYSE:HUM) has been assigned an average rating of “Hold” from the twenty-six research firms that are currently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a sell recommendation, sixteen have issued a hold recommendation and seven have given a buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $225.4783.

HUM has been the topic of a number of recent analyst reports. Leerink Partners dropped their price target on shares of Humana from $267.00 to $185.00 and set a “market perform” rating on the stock in a research report on Thursday, February 12th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a report on Thursday, January 22nd. TD Cowen dropped their target price on Humana from $260.00 to $173.00 and set a “hold” rating on the stock in a report on Friday, February 13th. JPMorgan Chase & Co. cut their target price on Humana from $274.00 to $180.00 and set a “neutral” rating for the company in a research report on Friday, February 13th. Finally, Raymond James Financial decreased their price target on Humana from $340.00 to $230.00 and set an “outperform” rating for the company in a research note on Friday, February 13th.

Insider Transactions at Humana

In other Humana news, insider Sanjay K. Shetty purchased 810 shares of the company’s stock in a transaction on Monday, February 23rd. The shares were purchased at an average cost of $185.21 per share, for a total transaction of $150,020.10. Following the completion of the transaction, the insider owned 11,657 shares in the company, valued at $2,158,992.97. The trade was a 7.47% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.20% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Humana

Several large investors have recently made changes to their positions in the business. Illinois Municipal Retirement Fund boosted its stake in shares of Humana by 9.6% during the 3rd quarter. Illinois Municipal Retirement Fund now owns 49,658 shares of the insurance provider’s stock worth $12,920,000 after acquiring an additional 4,351 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of Humana by 161.5% during the third quarter. Bank of New York Mellon Corp now owns 1,717,767 shares of the insurance provider’s stock valued at $446,911,000 after purchasing an additional 1,060,767 shares during the last quarter. National Pension Service lifted its holdings in shares of Humana by 2.8% during the third quarter. National Pension Service now owns 189,601 shares of the insurance provider’s stock valued at $49,328,000 after purchasing an additional 5,150 shares during the last quarter. Long Focus Capital Management LLC acquired a new position in shares of Humana in the 3rd quarter valued at $34,212,000. Finally, Tejara Capital Ltd purchased a new position in Humana in the 3rd quarter worth about $1,873,000. Institutional investors own 92.38% of the company’s stock.

Humana Trading Up 0.1%

Shares of HUM stock opened at $178.05 on Tuesday. Humana has a 1 year low of $163.11 and a 1 year high of $315.35. The firm has a market capitalization of $21.38 billion, a PE ratio of 18.13, a price-to-earnings-growth ratio of 1.90 and a beta of 0.44. The stock has a fifty day moving average of $182.32 and a two-hundred day moving average of $235.13. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.00 and a current ratio of 2.00.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) EPS for the quarter, beating analysts’ consensus estimates of ($4.01) by $0.05. The company had revenue of $32.64 billion for the quarter, compared to analyst estimates of $32.08 billion. Humana had a return on equity of 11.43% and a net margin of 0.92%.The company’s quarterly revenue was up 11.3% compared to the same quarter last year. During the same period last year, the company earned ($2.16) earnings per share. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, research analysts expect that Humana will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 27th. This represents a $3.54 annualized dividend and a yield of 2.0%. Humana’s dividend payout ratio (DPR) is currently 36.05%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.